Kyverna Therapeutics, Inc (KYTX) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Kyverna Therapeutics (KYTX) hozirda faol investitsiya bosqichida bo'lib, bunda murakkab sinov protokollari sezilarli xarajatlarni keltirib chiqarmoqda va masshtablashish hali mavjud emas. Ushbu sektor iqtisodiy sikllar yoki mavsumiylikka bog'liq emas, bu esa tashqi zarbalarga chidamlilikni namoyish etadi. separate_debt_long_eq metriki uchun ushbu grafik 0.19 ko'rsatkichini aks ettirib, og'ir skleroz va tizimli qizil tizrakka qarshi kurashish uchun innovatsion immun qayta dasturlash usullarini ishlab chiqish bo'yicha ma'lumotlarni to'ldiradi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_KYTX_-_Kyverna-Therapeutics_-_Long-Term-Debt-to-Capital "KYTX: Kyverna Therapeutics, Inc. Uzoq muddatli qarzning kapitalga nisbati 21.02.2024 - 01.11.2026 | 👁️GURU.Markets👁️")
Kyverna Therapeutics (KYTX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Kyverna Therapeutics|KYTX - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati kyvernatx.com|KYTX - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Kyverna Therapeutics, Inc.|KYTX - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Kyverna Therapeutics|Tezkor likvidlik ko‘rsatkichi kyvernatx.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Kyverna Therapeutics Inc. - KYTX
Moslashuvchanlikni saqlash uchun ishlab chiqarish va sinovlarni autsorsingga tayanadigan Kyverna Therapeutics (KYTX) uchun uzoq muddatli qarzdorlikning kapitalga nisbati moliyaviy mustaqillik ko'rsatkichi bo'lib xizmat qiladi. Ushbu metrika bir yildan ortiq muddatga ega bo'lgan kreditlarning kapitalga nisbati sifatida hisoblanadi, bu esa investorlarga qarz mablag'lari hisobiga o'sish va biznesning fundamental barqarorligiga haddan tashqari kredit yuklamasi (leverage) keltirishi mumkin bo'lgan xavf o'rtasidagi muvozanatni baholash imkonini beradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Precigen (PGEN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Pharming Group NV|Uzoq muddatli qarzning o'z kapitaliga nisbati NKTR|Uzoq muddatli qarzning kapitalga nisbati Upstream Pharma|Uzoq muddatli qarzning o'z kapitaliga nisbati Zenas Biopharma Inc (ZBIO)|immunome.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati GOSS (Gossamer Bio)|KalVista Pharma (KALV) - Uzoq muddatli majburiyatlarning kapitalga nisbati|SEPN - Uzoq muddatli qarzning o'z kapitaliga nisbati|PVLA - Uzoq muddatli qarzning kapitalga nisbati|SVRA (Savara Inc.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati rigel.com (RIGL)|Uzoq muddatli qarzning o'z kapitaliga nisbati ANAB|Uzoq muddatli qarzning o'z kapitaliga nisbati ATXS|Uzoq muddatli qarzning kapitalga nisbati ENGN|RAPT - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Aerovate Therapeutics JBIO|Uzoq muddatli qarzning kapitalga koeffitsiyenti ACRS|TLSA - Uzoq muddatli qarzning o'z kapitaliga nisbati|CABA (Cabaletta Bio Inc.) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|VTYX: Uzoq muddatli qarzning kapitalga nisbati|Theratechnologies, Inc (THTX) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AVTX|ELDN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|Uzoq muddatli kreditlarning kapitalga nisbati CLYM|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzning kapitalga koeffitsiyenti ATYR|Adagene Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati ImageneBio Inc|shattucklabs.com (STTK) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Equillium - Uzoq muddatli qarzning kapitalga koeffitsiyenti|CNTB (Connect Biopharma Holdings) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Immunic Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Adicet Bio Inc. (ACET) - Uzoq muddatli majburiyatlarning kapitalga nisbati|CELU: Uzoq muddatli qarzning o'z kapitaliga nisbati|INMB - Uzoq muddatli qarzning kapitalga nisbati|BRNS (Barinthus Biotherapeutics) - Uzoq muddatli qarzning o'z kapitaliga nisbati|KZR: Uzoq muddatli kreditlarning kapitalga nisbati|SABS (SAB Biotherapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Akari Therapeutics PLC (AKTX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|Uzoq muddatli qarzning o'z kapitaliga nisbati q32bio.com QTTB|Uzoq muddatli qarzning o'z kapitaliga nisbati GeoVax Labs, Inc. GOVX|Uzoq muddatli qarzdorlikning kapitalga nisbati edesabiotech.com (EDSA)|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|CARM - Uzoq muddatli qarzning kapitalga nisbati|XTLB (XTL Biopharmaceuticals, Ltd.) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Bolt Biotherapeutics, Inc. (BOLT)|Uzoq muddatli qarzning o'z kapitaliga nisbati HCWB|APVO (Aptevo) - Uzoq muddatli kreditlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|aditxt.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning o'z kapitaliga nisbati GRI Bio Corp GRI|XRTX (XORTX Corp) - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Vyome Holdings Inc - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti REVB (revbiosciences.com)|INDP: Uzoq muddatli qarzning kapitalga nisbati|Scinai Immunotherapeutics Ltd (SCNI) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati CalciMedica Inc|AFMD: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|Uzoq muddatli qarzning o'z kapitaliga nisbati hookipapharma.com HOOK|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|Uzoq muddatli qarzning kapitalga nisbati iTeos Therapeutics Inc ITOS|OCEA: Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti TCBP (TC BioPharm Ltd)|THRD: Uzoq muddatli qarzning kapitalga nisbati